Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo

Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which differentcancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent M...

Full description

Bibliographic Details
Main Authors: Woll, P, Kjällquist, U, Chowdhury, O, Doolittle, H, Wedge, D, Thongjuea, S, Erlandsson, R, Ngara, M, Anderson, K, Deng, Q, Mead, A, Stenson, L, Giustacchini, A, Duarte, S, Giannoulatou, E, Taylor, S, Karimi, M, Scharenberg, C, Mortera-Blanco, T, Macaulay, I, Clark, S, Dybedal, I, Josefsen, D, Fenaux, P, Hokland, P
Format: Journal article
Language:English
Published: Cell Press 2014
_version_ 1826280496650256384
author Woll, P
Kjällquist, U
Chowdhury, O
Doolittle, H
Wedge, D
Thongjuea, S
Erlandsson, R
Ngara, M
Anderson, K
Deng, Q
Mead, A
Stenson, L
Giustacchini, A
Duarte, S
Giannoulatou, E
Taylor, S
Karimi, M
Scharenberg, C
Mortera-Blanco, T
Macaulay, I
Clark, S
Dybedal, I
Josefsen, D
Fenaux, P
Hokland, P
author_facet Woll, P
Kjällquist, U
Chowdhury, O
Doolittle, H
Wedge, D
Thongjuea, S
Erlandsson, R
Ngara, M
Anderson, K
Deng, Q
Mead, A
Stenson, L
Giustacchini, A
Duarte, S
Giannoulatou, E
Taylor, S
Karimi, M
Scharenberg, C
Mortera-Blanco, T
Macaulay, I
Clark, S
Dybedal, I
Josefsen, D
Fenaux, P
Hokland, P
author_sort Woll, P
collection OXFORD
description Evidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which differentcancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenitors. All identified somatically acquired genetic lesions were backtracked to distinct MDS-SCs, establishing their distinct MDS-propagating function invivo. In isolated del(5q)-MDS, acquisition of del(5q) preceded diverse recurrent driver mutations. Sequential analysis in del(5q)-MDS revealed genetic evolution in MDS-SCs and MDS-progenitors prior to leukemic transformation. These findings provide definitive evidence for rare human MDS-SCs invivo, with extensive implications for the targeting of the cells required and sufficient for MDS-propagation. © 2014 Elsevier Inc.
first_indexed 2024-03-07T00:14:35Z
format Journal article
id oxford-uuid:7a615fc6-24b9-4111-a39c-96723d0d0b73
institution University of Oxford
language English
last_indexed 2024-03-07T00:14:35Z
publishDate 2014
publisher Cell Press
record_format dspace
spelling oxford-uuid:7a615fc6-24b9-4111-a39c-96723d0d0b732022-03-26T20:43:45ZMyelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivoJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a615fc6-24b9-4111-a39c-96723d0d0b73EnglishSymplectic Elements at OxfordCell Press2014Woll, PKjällquist, UChowdhury, ODoolittle, HWedge, DThongjuea, SErlandsson, RNgara, MAnderson, KDeng, QMead, AStenson, LGiustacchini, ADuarte, SGiannoulatou, ETaylor, SKarimi, MScharenberg, CMortera-Blanco, TMacaulay, IClark, SDybedal, IJosefsen, DFenaux, PHokland, PEvidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which differentcancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenitors. All identified somatically acquired genetic lesions were backtracked to distinct MDS-SCs, establishing their distinct MDS-propagating function invivo. In isolated del(5q)-MDS, acquisition of del(5q) preceded diverse recurrent driver mutations. Sequential analysis in del(5q)-MDS revealed genetic evolution in MDS-SCs and MDS-progenitors prior to leukemic transformation. These findings provide definitive evidence for rare human MDS-SCs invivo, with extensive implications for the targeting of the cells required and sufficient for MDS-propagation. © 2014 Elsevier Inc.
spellingShingle Woll, P
Kjällquist, U
Chowdhury, O
Doolittle, H
Wedge, D
Thongjuea, S
Erlandsson, R
Ngara, M
Anderson, K
Deng, Q
Mead, A
Stenson, L
Giustacchini, A
Duarte, S
Giannoulatou, E
Taylor, S
Karimi, M
Scharenberg, C
Mortera-Blanco, T
Macaulay, I
Clark, S
Dybedal, I
Josefsen, D
Fenaux, P
Hokland, P
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title_full Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title_fullStr Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title_full_unstemmed Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title_short Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
title_sort myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
work_keys_str_mv AT wollp myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT kjallquistu myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT chowdhuryo myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT doolittleh myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT wedged myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT thongjueas myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT erlandssonr myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT ngaram myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT andersonk myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT dengq myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT meada myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT stensonl myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT giustacchinia myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT duartes myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT giannoulatoue myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT taylors myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT karimim myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT scharenbergc myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT morterablancot myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT macaulayi myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT clarks myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT dybedali myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT josefsend myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT fenauxp myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo
AT hoklandp myelodysplasticsyndromesarepropagatedbyrareanddistincthumancancerstemcellsinvivo